Israel’s IceCure already has US FDA approval for its cryogenic (freezing) treatment of cancer (reported here previously). The latest FDA Breakthrough Device designation, however, will speed up procedures regarding permits for IceCure’s Prosense device to treat cancer patients. https://www.timesofisrael.com/icecure-shares-up-as-tumor-freezing-tech-gets-fda-breakthrough-device-nod/

The US FDA has granted approval for Israel’s IceCure Medical to use its tumor-freezing technology to destroy cancerous and benign tumors of the kidney, liver, ear, nose, and throat. It already has FDA approval for benign breast tumors and European … Continue reading →